Publicação

Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma

Ver documento

Detalhes bibliográficos
Resumo:This study aimed to investigate the prognostic influence of DNA flow cytometry and RAS gene mutations in patients with poorly differentiated (PDTC) and anaplastic thyroid carcinoma (ATC). The series consisted of 26 patients with PDTC and ATC, and a median follow-up of 10 months (range 1-138). DNA ploidy and S-phase fraction (SPF) were assessed by flow cytometry on frozen samples. RAS point mutations were detected using PCR techniques. Disease staging and tumour angioinvasion were included as prognostic parameters for survival analysis. Nineteen patients (73.1%) succumbed to the disease (median time 5 months; range 1-45). Eighteen tumours (69.2%) were classified as DNA aneuploid. Median SPF was 5.6% (range 1.9-23.1), which was used as a cut-off value to distinguish between low versus high cell proliferation. Three of 20 (15%) patients presented N-RAS gene mutations in codon 61. DNA aneuploidy was most frequently found in female patients (p=0.034). Kaplan-Meier and Cox regression analyses showed that only DNA aneuploidy (p=0.044 and p=0.055, respectively) and high SPF (p=0.001 and p=0.006, respectively) significantly correlated with worse survival. The results indicate that aneuploidy and high SPF are biomarkers of poor clinical outcome in PDTC and ATC, which may provide useful prognostic information with a potentially therapeutic impact in patient management.
Autores principais:Pinto, António E.
Outros Autores:Silva, Giovani; Banito, Ana; Leite, Valeriano; Soares, Jorge
Assunto:Anaplastic thyroid carcinoma DNA ploidy Poorly differentiated thyroid carcinoma Prognosis RAS mutations S-phase fraction Cancer Research Oncology SDG 3 - Good Health and Well-being
Ano:2008
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Universidade Nova de Lisboa
Idioma:inglês
Origem:Repositório Institucional da UNL
_version_ 1868983502191460352
author Pinto, António E.
author2 Silva, Giovani
Banito, Ana
Leite, Valeriano
Soares, Jorge
author2_role author
author
author
author
author_facet Pinto, António E.
Silva, Giovani
Banito, Ana
Leite, Valeriano
Soares, Jorge
author_role author
contributor_name_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
Spandidos Publications
RUN
country_str PT
creators_json_txt [{\"Person.name\":\"Pinto, António E.\"},{\"Person.name\":\"Silva, Giovani\"},{\"Person.name\":\"Banito, Ana\"},{\"Person.name\":\"Leite, Valeriano\"},{\"Person.name\":\"Soares, Jorge\"}]
datacite.contributors.contributor.contributorName.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
Spandidos Publications
RUN
datacite.creators.creator.creatorName.fl_str_mv Pinto, António E.
Silva, Giovani
Banito, Ana
Leite, Valeriano
Soares, Jorge
datacite.date.Accepted.fl_str_mv 2008-10-01T00:00:00Z
datacite.date.available.fl_str_mv 2022-07-21T00:31:29Z
datacite.date.embargoed.fl_str_mv 2022-07-21T00:31:29Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv Anaplastic thyroid carcinoma
DNA ploidy
Poorly differentiated thyroid carcinoma
Prognosis
RAS mutations
S-phase fraction
Cancer Research
Oncology
SDG 3 - Good Health and Well-being
datacite.titles.title.fl_str_mv Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma
dc.contributor.none.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
Spandidos Publications
RUN
dc.creator.none.fl_str_mv Pinto, António E.
Silva, Giovani
Banito, Ana
Leite, Valeriano
Soares, Jorge
dc.date.Accepted.fl_str_mv 2008-10-01T00:00:00Z
dc.date.available.fl_str_mv 2022-07-21T00:31:29Z
dc.date.embargoed.fl_str_mv 2022-07-21T00:31:29Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://hdl.handle.net/10362/142149
dc.language.none.fl_str_mv eng
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.subject.none.fl_str_mv Anaplastic thyroid carcinoma
DNA ploidy
Poorly differentiated thyroid carcinoma
Prognosis
RAS mutations
S-phase fraction
Cancer Research
Oncology
SDG 3 - Good Health and Well-being
dc.title.fl_str_mv Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
description This study aimed to investigate the prognostic influence of DNA flow cytometry and RAS gene mutations in patients with poorly differentiated (PDTC) and anaplastic thyroid carcinoma (ATC). The series consisted of 26 patients with PDTC and ATC, and a median follow-up of 10 months (range 1-138). DNA ploidy and S-phase fraction (SPF) were assessed by flow cytometry on frozen samples. RAS point mutations were detected using PCR techniques. Disease staging and tumour angioinvasion were included as prognostic parameters for survival analysis. Nineteen patients (73.1%) succumbed to the disease (median time 5 months; range 1-45). Eighteen tumours (69.2%) were classified as DNA aneuploid. Median SPF was 5.6% (range 1.9-23.1), which was used as a cut-off value to distinguish between low versus high cell proliferation. Three of 20 (15%) patients presented N-RAS gene mutations in codon 61. DNA aneuploidy was most frequently found in female patients (p=0.034). Kaplan-Meier and Cox regression analyses showed that only DNA aneuploidy (p=0.044 and p=0.055, respectively) and high SPF (p=0.001 and p=0.006, respectively) significantly correlated with worse survival. The results indicate that aneuploidy and high SPF are biomarkers of poor clinical outcome in PDTC and ATC, which may provide useful prognostic information with a potentially therapeutic impact in patient management.
dirty 0
eu_rights_str_mv openAccess
format article
fulltext.url.fl_str_mv https://run.unl.pt/bitstreams/67792b57-a228-4826-bc05-e5056fb7c031/download
id run_313be683c92bbab8a16b35a67d1c7a0d
identifier.url.fl_str_mv http://hdl.handle.net/10362/142149
inst_facet_str urn:organizationAcronym:unl{{{_:::_}}}Universidade Nova de Lisboa
instacron_str unl
institution Universidade Nova de Lisboa
instname_str Universidade Nova de Lisboa
language eng
network_acronym_str run
network_name_str Repositório Institucional da UNL
oai_identifier_str oai:run.unl.pt:10362/142149
organization_str_mv urn:organizationAcronym:unl
person_str_mv Pinto, António E.
Silva, Giovani
Banito, Ana
Leite, Valeriano
Soares, Jorge
publishDate 2008
repo_facet_str urn:repositoryAcronym:run{{{_:::_}}}Repositório Institucional da UNL
reponame_str Repositório Institucional da UNL
repository_id_str urn:repositoryAcronym:run
service_str_mv urn:repositoryAcronym:run
spelling engenThis study aimed to investigate the prognostic influence of DNA flow cytometry and RAS gene mutations in patients with poorly differentiated (PDTC) and anaplastic thyroid carcinoma (ATC). The series consisted of 26 patients with PDTC and ATC, and a median follow-up of 10 months (range 1-138). DNA ploidy and S-phase fraction (SPF) were assessed by flow cytometry on frozen samples. RAS point mutations were detected using PCR techniques. Disease staging and tumour angioinvasion were included as prognostic parameters for survival analysis. Nineteen patients (73.1%) succumbed to the disease (median time 5 months; range 1-45). Eighteen tumours (69.2%) were classified as DNA aneuploid. Median SPF was 5.6% (range 1.9-23.1), which was used as a cut-off value to distinguish between low versus high cell proliferation. Three of 20 (15%) patients presented N-RAS gene mutations in codon 61. DNA aneuploidy was most frequently found in female patients (p=0.034). Kaplan-Meier and Cox regression analyses showed that only DNA aneuploidy (p=0.044 and p=0.055, respectively) and high SPF (p=0.001 and p=0.006, respectively) significantly correlated with worse survival. The results indicate that aneuploidy and high SPF are biomarkers of poor clinical outcome in PDTC and ATC, which may provide useful prognostic information with a potentially therapeutic impact in patient management.application/pdfenAneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinomaPinto, António E.Silva, GiovaniBanito, AnaLeite, ValerianoSoares, JorgeNOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)Spandidos PublicationsHostingInstitutionOrganizationalRUNe-mailmailto:run@unl.ptrun@unl.ptISSNIsPartOf1021-335XURNIsPartOfPURE: 3152340URNIsPartOfPURE UUID: 19c72bf5-55fa-4913-ac33-cdbaca49e720URNIsPartOfScopus: 54949150226URNIsPartOfPubMed: 18813835URNIsPartOfWOS: 000259767400030DOIIsPartOf10.3892/or_000000912022-07-21T00:31:29Z2008-102008-10-01T00:00:00ZHandlehttp://hdl.handle.net/10362/142149http://purl.org/coar/access_right/c_abf2open accessAnaplastic thyroid carcinomaDNA ploidyPoorly differentiated thyroid carcinomaPrognosisRAS mutationsS-phase fractionCancer ResearchOncologySDG 3 - Good Health and Well-being214982 bytesliteraturehttp://purl.org/coar/resource_type/c_6501journal articlehttp://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://run.unl.pt/bitstreams/67792b57-a228-4826-bc05-e5056fb7c031/download
spellingShingle Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma
Pinto, António E.
Anaplastic thyroid carcinoma
DNA ploidy
Poorly differentiated thyroid carcinoma
Prognosis
RAS mutations
S-phase fraction
Cancer Research
Oncology
SDG 3 - Good Health and Well-being
status SINGLETON
subject.fl_str_mv Anaplastic thyroid carcinoma
DNA ploidy
Poorly differentiated thyroid carcinoma
Prognosis
RAS mutations
S-phase fraction
Cancer Research
Oncology
SDG 3 - Good Health and Well-being
title Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma
title_full Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma
title_fullStr Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma
title_full_unstemmed Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma
title_short Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma
title_sort Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma
topic Anaplastic thyroid carcinoma
DNA ploidy
Poorly differentiated thyroid carcinoma
Prognosis
RAS mutations
S-phase fraction
Cancer Research
Oncology
SDG 3 - Good Health and Well-being
topic_facet Anaplastic thyroid carcinoma
DNA ploidy
Poorly differentiated thyroid carcinoma
Prognosis
RAS mutations
S-phase fraction
Cancer Research
Oncology
SDG 3 - Good Health and Well-being
url http://hdl.handle.net/10362/142149
visible 1